statslady23 t1_iych4jf wrote on November 30, 2022 at 11:08 AM

Reply to comment by [deleted] in Alzheimer's drug lecanemab hailed as momentous breakthrough by Methoszs

It's just like the US drug Aduhelm. It's $56000 per year, and Medicare doesn't cover it yet. Plaque reduction has implications for CTE, Parkinson's, maybe long-term covid, etc. I talked to one of the Aduhelm researchers at a dinner party recently who said other similar drugs are close on the horizon. Exciting times for this area of neuro research for sure.

SimbaOnSteroids t1_iyem5jn wrote on November 30, 2022 at 8:41 PM

You’re getting downvoted but this is in-line with what one of the Aduhelm researches told me. Removing amyloid plaques may prove to be important but it’s clearly not the whole picture.